verified SJR 0,694 · Q2 • database Scopus / SJR & Web of Science indexed

Switzerland

workspace_premium Q2 — Pharmacology lock Subscription

European Journal of Drug Metabolism and Pharmacokinetics

European Journal of Drug Metabolism and Pharmacokinetics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 50. It has a price of 2690 €. It has an SJR impact factor of 0,694 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,694.

ISSN: 0378-7966

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,694 Q2

H-index 50

Acceptance rate pie_chart

33%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.690 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,694

H-index

Docs (year)

Docs 3y

198

Total refs

2790

Cites 3y

511

Citable 3y

189

Cites/Doc 2y

2.7

Ref/Doc

45.74

Immediate OA

2690 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Are we doing too many animal biodisposition investigations before Phase I studies in man?

Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer

Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population

Comparison of the pharmacokinetics of linezolid in burn and non-burn rabbits

Comparison of pharmacokinetic and safety profiles between Bemfola¬Æ and Gonal-f¬Æ after subcutaneous application

Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats

Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs

Combining Chemical Permeation Enhancers for Synergistic Effects

Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin

Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives

Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F

Autoradiography in brain ofMacaca fascicularis monkeys after injection of acetyl-DL-leucine [2-14C] (Tanganil¬Æ)

SHOW MORE ARTICLES

Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment

A comparison of the distribution of two glycyrrhizic acid epimers in rat tissues

Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter

Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats

Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization

Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation

Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications

A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data

A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid

A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics

A metoprolol-terbinafine combination induced bradycardia

FAQs

European Journal of Drug Metabolism and Pharmacokinetics has an SJR of 0,694 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2690 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for European Journal of Drug Metabolism and Pharmacokinetics is 33%.

European Journal of Drug Metabolism and Pharmacokinetics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of European Journal of Drug Metabolism and Pharmacokinetics?

What is the APC / publication cost?

What is the acceptance rate?